Sinovac Biotech current Real Value cannot be determined due to lack of data. The regular price of Sinovac Biotech is $0.0. Based on Macroaxis valuation methodology, the company cannot be evaluated at this time. This module measures value of Sinovac Biotech from inspecting the company fundamentals such as Shares Outstanding of 57.02M, Return On Equity of
11.53% and Operating Margin of 16.19% as well as reviewing its technical indicators and Probability Of Bankruptcy. In general, we recommend to buy undervalued stocks and to dispose of overvalued stocks since at some point securities prices and their ongoing real values will draw towards each other.
|Horizon||30 Days Login to change|
Sinovac Biotech Ltd is rated third in price to sales category among related companies. It is rated third in price to book category among related companies fabricating about 0.98 of Price to Book per Price to Sales. The ratio of Price to Sales to Price to Book for Sinovac Biotech Ltd is roughly 1.02
|Price to Sales ( times )|
|Price to Book ( times )|